Compare ConocoPhillips (COP) vs Koninklijke Philips NV (PHG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ConocoPhillips vs Koninklijke Philips NV — how do they compare? ConocoPhillips trades at $135.16 (market cap $161.21B), while Koninklijke Philips NV trades at $24.32 (market cap $23.52B). The key difference: ConocoPhillips is far larger — about 6.9× Koninklijke Philips NV's market cap, and Koninklijke Philips NV pays the higher dividend (4.17%). Which is the better fit depends on your goals — on Pluang, investors hold ConocoPhillips for 79 Days and Koninklijke Philips NV for 84 Days on average.
| COP | PHG | |
|---|---|---|
Market Cap | $161.21B | $23.52B |
Volume | 6,058,403 | 1,635,069 |
Sector | Energy | Health |
52-Week High | $141.22 | $32.91 |
52-Week Low | $85.66 | $23.81 |
Typical Hold Time | 79 Days | 84 Days |
Enterprise Value | $176.81B | $29.87B |
Dividend Yield | 2.5% | 4.17% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ConocoPhillips (COP) trades at $129.84, up 0.38% today, with strong technical momentum and bullish moving average signals. The company reported mixed Q4 2025 earnings but beat expectations in Q1 and Q2 2026, with revenue growth from $58.94B in 2025 to projected $63.3B in 2026. Recent developments include a 20-year LNG supply agreement with Venture Global and potential asset sales in Norway and the UK, signaling strategic portfolio optimization.
COP presents a compelling investment case with solid fundamentals—P/E of 17.75, ROE of 14.14%, and robust cash flow—supported by a 75% analyst buy rating and $154.75 consensus price target. Key risks include geopolitical exposure in the Middle East, oil price volatility, and execution of asset sales. The stock's current level near resistance at $130 suggests near-term consolidation potential amid bullish long-term prospects.
PHG trades at $24.09, down 0.25% with a bearish technical signal. The company shows improving fundamentals with three consecutive quarterly EPS beats and a return to profitability in 2025 (net income $895M). Recent news highlights innovation in healthcare technology including new product launches and AI partnerships. Valuation metrics appear reasonable with P/E of 18.94 and P/S of 1.18.
PHG presents a mixed outlook with strong operational recovery but technical weakness. The investment case hinges on continued earnings momentum and successful execution of healthcare technology initiatives. Key risks include competitive pressures and potential cybersecurity vulnerabilities following recent hacking incidents. Analyst consensus leans neutral with 36% buy ratings versus 64% hold.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About ConocoPhillips
ConocoPhillips is a U.S.-based independent exploration and production firm. In 2021, it produced 1.0 million barrels per day of oil and natural gas liquids and 3.2 billion cubic feet per day of natural gas, primarily from Alaska and the Lower 48 in the United States and Norway in Europe and several countries in Asia-Pacific and the Middle East. Proven reserves at year-end 2021 were 6.1 billion barrels of oil equivalent.
Read more on COP →About Koninklijke Philips NV
Philips is a diversified global healthcare company operating in three segments: diagnosis and treatment, connected care, and personal health. About 50% of the company's revenue comes from the diagnosis and treatment segment, which features imaging systems, ultrasound equipment, image-guided therapy solutions and healthcare informatics. The connected care segment (27% of revenue) encompasses monitoring and analytics systems for hospitals and sleep and respiratory care devices, whereas the personal health business (remainder of revenue) includes electric toothbrushes and men's grooming and personal-care products. In 2021, Philips generated EUR 17.2 billion in sales and had 80,000 employees in over 100 countries.
Read more on PHG →
